Adagene Stock (NASDAQ:ADAG), Quotes and News Summary

Q: What sector and industry does Adagene (ADAG) operate in?

Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Adagene Stock (NASDAQ: ADAG) stock price, news, charts, stock research, profile.

Open	$2.680
Close	-
Volume / Avg.	6.071K / 38.380K
Day Range	2.420 - 2.771
52 Wk Range	1.100 - 4.380
Market Cap	$113.925M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	0.04%
Days to Cover	1.11

Recent News

Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.

Avi Kapoor

Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan Networks Holdings shares surged 381% to $0.3699 on Wednesday.

Avi Kapoor

Why Is Cancer Focused Adagene Stock Plummeting Today?

Adagene presents results at ASCO 2024 Gastrointestinal Cancers Symposium. ADG126, combined with Merck's Keytruda, shows limited toxicity, sustained partial responses, and a 22% overall response rate in Colorectal Cancer patients. ADAG shares currently down 47.1% at $2.0."

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Adagene Inc

Sector

Health Care

Industry

Biotechnology

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the di...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Adagene (ADAG) stock?

You can purchase shares of Adagene (NASDAQ: ADAG) through any online brokerage.

View our list of the best stock brokerages.

Who are Adagene's (ADAG) competitors?

Other companies in Adagene’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), CytomX Therapeutics (NASDAQ:CTMX), Vistagen Therapeutics (NASDAQ:VTGN), GlycoMimetics (NASDAQ:GLYC) and Sangamo Therapeutics (NASDAQ:SGMO).

What is the target price for Adagene (ADAG) stock?

The latest price target for Adagene (NASDAQ: ADAG) was reported by HC Wainwright & Co. on Wednesday, October 4, 2023. The analyst firm set a price target for 5.00 expecting ADAG to rise to within 12 months (a possible 93.80% upside). 2 analyst firms have reported ratings in the last year.

Current Stock Price for Adagene (ADAG)?

The stock price for Adagene (NASDAQ: ADAG) is $2.58 last updated April 23, 2024 at 4:02 AM EDT.

Does Adagene (ADAG) pay a dividend?

There are no upcoming dividends for Adagene.

When is Adagene (NASDAQ:ADAG) reporting earnings?

Adagene’s FY earnings are confirmed for Tuesday, May 7, 2024.

Is Adagene (ADAG) going to split?

There is no upcoming split for Adagene.

What sector and industry does Adagene (ADAG) operate in?

Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-